Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Myriad Genetics
 More »

  • Companion Diagnostics: 52 Pick-Up
    ... Financial terms not disclosed. Myriad Genetics and Teva Pharmaceutical (Cephalon) Agreement announced March 28, 2012 Collaboration to test for BRCA1 and BRCA2 mutation via Myriad's ...
    5-9-2013
  • Biomarkers Take Center Stage
    ... Developing New Assays for Cancer Biomarkers Researchers at Myriad RBM and the Cancer ... Nothing-from lifestyle choices to birth order to ancestral genetics and epigenetics-is off ...
    5-1-2013
  • $20M in Financing Helps RainDance Summon ThunderStorms for Myriad
    In addition to making some money, RainDance Technologies has made a new friend: RainDance is closing a $20 million Series E financing round, and Myriad Genetics is now a new ...
    4-29-2013
  • GEN | Biolinks
    ... Inovio Pharmaceuticals Insight Genetics Institute of Biological Research and ... MP Biomedicals MPI Research MPI Research Mucosis Myocept, Inc Myriad RBM Myriant ...
  • In Gene Patenting Case, a Myriad of Analogies
    which the justices posed questions using analogies of plants from the Amazon and chocolate chip cookies, while plaintiff Myriad Genetics invoked its own metaphor of a baseball bat. ...
    4-15-2013
  • On Supreme Court Docket: Whose Gene Is It Anyway?
    cancer susceptibility genes BRCA 1 and 2. At issue is the validity of the seven patents issued to Myriad Genetics for BRCA 1 and 2 by the U.S. Patent and Trademark Office (USPTO). ...
    4-14-2013
  • Who Owns Your Genes?
    The U.S. Supreme Court will review genomic patent rights in an upcoming hearing on April 15. At issue is the right of Myriad Genetics to claim patents not only on two key breast ...
    3-27-2013
  • Myriad to Use New HRD Test with PharmaMar's DNA-Damaging Drug
    Molecular diagnostics company Myriad Genetics signed an agreement with PharmaMar, a company that specializes in developing marine-derived drugs, under which Myriad will conduct ...
    3-27-2013
  • Diagnostic Tests and Patent Eligibility
    Myriad Genetics . "The key distinction, which bears on our decision today...is between claims that recite ineligible subject matter, and no more, and claims to specific inventive ...
    3-1-2013
  • Protecting Personalized Medicine Inventions
    ... The ACLU has sued the U.S. Patent & Trademark Office and exclusive licensee Myriad Genetics on behalf of a group of doctors, researchers, and others, arguing that these ...
    2-1-2013
  • Biggest Biotech Trends of 2012
    ... CAFC in August reaffirmed the mixed ruling it rendered a year earlier on seven BRCA-related patents held by Myriad Genetics. That court found Myriad's gene composition-of-matter ...
    1-15-2013
  • 7 Biotech Trends for the Coming Year
    ... MOMENTA & MYRIAD: Patent Cases Head for Supreme Court The Supreme Court in 2013 will hear ... CAFC in August found Myriad Genetics' gene composition-of-matter claims and methods of ...
    1-3-2013
  • Biggest Biotech Trends of 2012
    ... CAFC in August reaffirmed the mixed ruling it rendered a year earlier on seven BRCA-related patents held by Myriad Genetics. That court found Myriad's gene composition-of-matter ...
    12-26-2012
  • Myriad, Sanofi Forge Potentially $10M Diabetes Collab
    Myriad RBM, a subsidiary of Myriad Genetics, entered a research collaboration with Sanofi and Population Health Research Institute (PHRI) at Hamilton Health Sciences and McMaster ...
    12-11-2012
  • Gene Patenting Faces Supreme Test
    At issue is the validity of the seven patents issued to Myriad Genetics for BRCA 1 and 2 by the U.S. Patent and Trademark Office (USPTO). In 2009, 20 medical associations and ...
    12-3-2012

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll